Reduced intensity allogeneic hematopoietic stem cell transplantion for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

We report a consecutive series of 59 patients with MDS who underwent reduced-intensity hematopoietic stem cell transplantation (RI-HSCT) with fludarabine/melphalan conditioning and tacrolimus/sirolimus-based GVHD prophylaxis. Two-year OS, EFS, and relapse incidences were 75.1%, 65.2%, and 20.9%, res...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nakamura, Ryotaro, Palmer, Joycelynne M., O'Donnell, Margaret R., Stiller, Tracey, Thomas, Sandra H., Chao, Joseph, Alvarnas, Joseph, Parker, Pablo M., Pullarkat, Vinod, Maegawa, Rodrigo, Stein, Anthony S., Snyder, David S., Bhatia, Ravi, Chang, Karen, Wang, Shirong, Cai, Ji-Lian, Senitzer, David, Forman, Stephen J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433241/
https://ncbi.nlm.nih.gov/pubmed/22677229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.04.022
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi